Caforio Giovanni
SEC CIK 1533201 · EDGAR
BoughtSold
Most active insiders at SYK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | STRYKER RONDA E | Dir | — | $580.89M |
| 2 | Fink M Kathryn | VP, Chief HR Off | — | $2.47M |
| 3 | Fletcher Robert S | VP, CLO | — | $1.39M |
| 4 | Berry William E Jr | VP, CAO | — | $713.8K |
| 5 | King Debra | See Remarks | — | $277.8K |
| 6 | Pierce James Andrew | Group Pres | — | $175.2K |
| 7 | Crotty Dylan Bram | Group Pres | — | $144.9K |
| 8 | Wells Preston Wendell | VP, CFO | — | $60.4K |
| 9 | Maceda Emmanuel Perez | Dir | — | — |
| 10 | Montagnino Kimberly Ann | VP, Chief Comm. Off | — | — |
| 16 | Caforio Giovanni | Dir | — | — |
Transactions 25
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-08 16:38 | 2026-05-06 | SYK | Stryker Corporation | Caforio Giovanni | Dir | A - Grant | $0.00 | +762 | 4,530 | +20% | $0 | |
| 2025-05-12 | 2025-05-08 | SYK | Stryker Corporation | Caforio Giovanni | Dir | A - Grant | $0.00 | +560 | 3,768 | +17% | $0 | |
| 2024-05-13 | 2024-05-09 | SYK | Stryker Corporation | Caforio Giovanni | Dir | A - Grant | $0.00 | +653 | 3,208 | +26% | $0 | |
| DM | 2024-03-12 | 2024-03-10 | BMY | Bristol Myers Squibb | Caforio Giovanni | Executive COB of the Board, Dir | M - OptEx | $0.00 | +190.1K | 390.9K | +95% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Bristol Myers Squibb | Caforio Giovanni | Executive COB of the Board, Dir | F - Tax | $53.79 | -67.8K | 386.8K | -15% | -$3.65M |
| DM | 2024-03-12 | 2024-03-10 | BMY | Bristol Myers Squibb | Caforio Giovanni | Executive COB of the Board, Dir | J - Other | $0.00 | -57.5K | 396.8K | -13% | $0 |
| 2023-10-12 | 2023-10-10 | BMY | Bristol Myers Squibb | Caforio Giovanni | CEO, Board COB, Dir | G - Gift | $0.00 | -440 | 367.5K | -0.1% | $0 | |
| 2023-05-12 | 2023-05-10 | SYK | Stryker Corporation | Caforio Giovanni | Dir | A - Grant | $0.00 | +705 | 2,555 | +38% | $0 | |
| D | 2023-05-08 | 2023-05-04 | SYK | Stryker Corporation | Caforio Giovanni | Dir | M - OptEx | $0.00 | +841 | 1,850 | +83% | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | Bristol Myers Squibb | Caforio Giovanni | CEO, Board COB, Dir | M - OptEx | $0.00 | +234.7K | 301.9K | +349% | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | Bristol Myers Squibb | Caforio Giovanni | CEO, Board COB, Dir | F - Tax | $65.71 | -138.0K | 290.9K | -32% | -$9.07M |
| DM | 2023-03-14 | 2023-03-10 | BMY | Bristol Myers Squibb | Caforio Giovanni | CEO, Board COB, Dir | J - Other | $0.00 | +35.1K | 302.7K | +13% | $0 |
| 2023-02-08 | 2023-02-06 | BMY | Bristol Myers Squibb | Caforio Giovanni | CEO, Board COB, Dir | S - Sale | $74.65 | -240.0K | 236.1K | -50% | -$17.92M | |
| 2022-09-22 | 2022-09-20 | BMY | Bristol Myers Squibb | Caforio Giovanni | CEO, Board COB, Dir | S - Sale | $69.71 | -25.0K | 476.1K | -5% | -$1.74M | |
| 2022-09-16 | 2022-09-15 | BMY | Bristol Myers Squibb | Caforio Giovanni | CEO, Board COB, Dir | S - Sale | $71.84 | -50.0K | 501.1K | -9% | -$3.59M | |
| 2022-06-14 | 2022-06-13 | BMY | Bristol Myers Squibb | Caforio Giovanni | CEO, Board COB, Dir | S - Sale | $74.04 | -30.0K | 551.1K | -5% | -$2.22M | |
| D | 2022-05-06 | 2022-05-04 | SYK | Stryker Corporation | Caforio Giovanni | Dir | M - OptEx | $0.00 | +693 | 693 | New | $0 |
| 2022-03-23 | 2022-03-21 | BMY | Bristol Myers Squibb | Caforio Giovanni | CEO, Board COB, Dir | S - Sale | $71.52 | -25.0K | 581.5K | -4% | -$1.79M | |
| 2022-03-23 | 2022-03-22 | BMY | Bristol Myers Squibb | Caforio Giovanni | CEO, Board COB, Dir | G - Gift | $0.00 | -420 | 581.1K | -0.1% | $0 | |
| DM | 2022-03-14 | 2022-03-10 | BMY | Bristol Myers Squibb | Caforio Giovanni | CEO, Board COB, Dir | M - OptEx | $0.00 | +239.5K | 502.0K | +91% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | Bristol Myers Squibb | Caforio Giovanni | CEO, Board COB, Dir | J - Other | $0.00 | +72.5K | 495.1K | +17% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | Bristol Myers Squibb | Caforio Giovanni | CEO, Board COB, Dir | F - Tax | $68.42 | -158.9K | 478.6K | -25% | -$10.87M |
| 2022-02-28 | 2022-02-24 | BMY | Bristol Myers Squibb | Caforio Giovanni | CEO, Board COB, Dir | S - Sale | $67.00 | -30.0K | 453.5K | -6% | -$2.01M | |
| 2021-09-22 | 2021-09-20 | BMY | Bristol Myers Squibb | Caforio Giovanni | CEO, Board COB, Dir | S - Sale | $60.64 | -25.0K | 484.0K | -5% | -$1.52M | |
| 2021-08-04 | 2021-08-02 | BMY | Bristol Myers Squibb | Caforio Giovanni | COB, CEO, Dir | S - Sale | $68.58 | -20.0K | 509.0K | -4% | -$1.37M |
Purchase Sale Sale after option exercise All abbreviations